National Health Investors (NHI)
NYSE:NHI
Want to see NHI full AI Analyst Report?
Total Valuation
National Health Investors has a market cap or net worth of $3.70B. The enterprise value is $4.95B.
Market Cap$3.70B
Enterprise Value$4.95B
Share Statistics
National Health Investors has 48,471,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,471,080
Owned by Insiders2.41%
Owned by Institutions10.37%
Financial Efficiency
National Health Investors’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.97%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.97%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee12.62M
Profits Per Employee4.74M
Employee Count30
Asset Turnover0.14
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of National Health Investors is 24.4. National Health Investors’s PEG ratio is -7.19.
PE Ratio24.4
PS Ratio9.46
PB Ratio2.35
Price to Fair Value2.35
Price to FCF16.25
Price to Operating Cash Flow14.96
PEG Ratio-7.19
Income Statement
In the last 12 months, National Health Investors had revenue of 378.53M and earned 142.18M in profits. Earnings per share was 3.03.
Revenue378.53M
Gross Profit138.93M
Operating Income194.83M
Pretax Income140.79M
Net Income142.18M
EBITDA282.00M
Earnings Per Share (EPS)3.03
Cash Flow
In the last 12 months, operating cash flow was 246.77M and capital expenditures -20.68M, giving a free cash flow of 226.10M billion.
Operating Cash Flow246.77M
Free Cash Flow226.10M
Free Cash Flow per Share4.66
Dividends & Yields
National Health Investors pays an annual dividend of $0.92, resulting in a dividend yield of 4.73%
Dividend Per Share$0.92
Dividend Yield4.73%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.25
52-Week Price Change10.60%
50-Day Moving Average80.05
200-Day Moving Average77.97
Relative Strength Index (RSI)46.02
Average Volume (3m)417.91K
Important Dates
National Health Investors upcoming earnings date is Aug 10, 2026, Before Open (Confirmed).
Last Earnings DateMay 4, 2026
Next Earnings DateAug 10, 2026
Ex-Dividend Date―
Financial Position
National Health Investors as a current ratio of 2.48, with Debt / Equity ratio of 83.82%
Current Ratio2.48
Quick Ratio2.48
Debt to Market Cap0.33
Net Debt to EBITDA4.06
Interest Coverage Ratio3.40
Taxes
In the past 12 months, National Health Investors has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
National Health Investors EV to EBITDA ratio is 16.75, with an EV/FCF ratio of 21.45.
EV to Sales12.48
EV to EBITDA16.75
EV to Free Cash Flow21.45
EV to Operating Cash Flow19.66
Balance Sheet
National Health Investors has $24.95M in cash and marketable securities with $1.27B in debt, giving a net cash position of -$1.24B billion.
Cash & Marketable Securities$24.95M
Total Debt$1.27B
Net Cash-$1.24B
Net Cash Per Share-$25.68
Tangible Book Value Per Share$32.85
Margins
Gross margin is 61.26%, with operating margin of 51.47%, and net profit margin of 37.56%.
Gross Margin61.26%
Operating Margin51.47%
Pretax Margin37.19%
Net Profit Margin37.56%
EBITDA Margin74.50%
EBIT Margin52.35%
Analyst Forecast
The average price target for National Health Investors is $89.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$89.75
Price Target Upside4.79% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast16.91%
EPS Growth Forecast-1.91%